Emma Guttman-Yassky

1. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis
   2019/01/01 by Emma Guttman-Yassky, Robert Bissonnette, Benjamin Ungar +17 · 4 citations
2. Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized double-blinded placebo-controlled phase III trials
   2023/03/30 by Andrew Blauvelt, Jacob P. Thyssen, Jacob P Thyssen +19 · 26 citations
   Medicine · Immunology and Microbiology · #Dermatology and Skin Diseases #Psoriasis: Treatment and Pathogenesis #Asthma and respiratory diseases
3. The role of OX40 ligand/OX40 axis signalling in atopic dermatitis
   2024/06/03 by Emma Guttman‐Yassky, Emma Guttman-Yassky, Michael Croft +9 · 21 citations
   Medicine · #Dermatology and Skin Diseases #Asthma and respiratory diseases #Allergic Rhinitis and Sensitization